Seven Eight Capital’s Omnicell OMCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-21,529
Closed -$939K 444
2024
Q3
$939K Buy
+21,529
New +$811K 0.08% 421
2024
Q1
Sell
-39,413
Closed -$1.48M 758
2023
Q4
$1.48M Buy
+39,413
New +$1.45M 0.17% 182
2022
Q1
Sell
-1,114
Closed -$201K 650
2021
Q4
$201K Sell
1,114
-2,886
-72% -$501K 0.04% 416
2021
Q3
$594K Sell
4,000
-1,100
-22% -$169K 0.06% 402
2021
Q2
$772K Sell
5,100
-12,500
-71% -$1.74M 0.11% 325
2021
Q1
$2.11M Hold
17,600
0.49% 55
2020
Q4
$2.11M Buy
+17,600
New +$1.73M 0.48% 55
2019
Q2
Sell
-25,400
Closed -$2.05M 693
2019
Q1
$2.05M Buy
+25,400
New +$1.9M 0.11% 239

Other funds holding OMCL

Seven Eight Capital's OMCL Position: Q4 2024 in Review

Seven Eight Capital sold out of Omnicell (OMCL) in Q4 2024, closing a stake of 21,529 shares — an estimated $939K sold.

Seven Eight Capital first reported a position in OMCL in Q1 2019 and held it in 8 quarters. The position peaked at $2.11M in Q1 2021. 279 funds tracked by Wall St. Rank hold OMCL as of Q4 2024.

  • Seven Eight Capital reported no remaining Omnicell position as of Q4 2024 after selling out during the quarter.
  • Seven Eight Capital sold 21,529 Omnicell shares in Q4 2024, an estimated $939K.
  • Seven Eight Capital first reported a position in Omnicell in Q1 2019 and held it in 8 quarters.
  • Seven Eight Capital's Omnicell position peaked at $2.11M in Q1 2021.
  • 279 funds tracked by Wall St. Rank held Omnicell as of Q4 2024.

Based on Seven Eight Capital's 13F filing for Q4 2024.